Treatment of lyso paf-mediated mental or neuronal disorders with lyso paf or paf antagonists and procedure for determining their efficacy
AssigneeRuth Korth
InventorRuth Korth
Life of this patent
Estimating the term…
Abstract
The invention refers to the treatment and prevention of lyso paf-mediated disorders with an effective amount of at least one antagonists against lyso paf receptors. Lyso paf or paf receptor antagonists were administered with or without an antagonist against production of ether phospholipids. Lyso paf antagonists are Ginkgoloides which are administered, for example, by food or topically.
Claims7
A method of treating or preventing lyso paf-mediated mental or neuronal disorders in a patient in need thereof or at risk of developing such disorders, the method comprising administering to the patient a lyso paf-antagonizing effective amount of a composition comprising a ginkgoloid.
Dependencies are inferred from the claim text.